Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuncheng Jin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical & Translational Immunology|January 15, 2024
A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancerMingzhen Zhou, Yuncheng Jin, Sihui Zhu, et al.
BMC Cancer|July 7, 2024
KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancerSihui Zhu, Yuncheng Jin, Mingzhen Zhou, et al.
BMC Cancer|October 14, 2024
Nomograms predicting benefit after immunotherapy in oral bifidobacteria supplementation ICC patients: a retrospective studySihui Zhu, Yuncheng Jin, Juan Zhang, et al.
Optics Express|July 19, 2020
Wavefront reconstruction based on deep transfer learning for microscopyYuncheng Jin, Jiajia Chen, Chenxue Wu, et al.
Journal of Hepatocellular Carcinoma|February 13, 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving RadiotherapyZhan Shi, Sihui Zhu, Yuncheng Jin, et al.
Optics Express|November 25, 2018
Machine learning guided rapid focusing with sensor-less aberration correctionsYuncheng Jin, Yiye Zhang, Lejia Hu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical & Translational Immunology|January 15, 2024
A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancerMingzhen Zhou, Yuncheng Jin, Sihui Zhu, et al.
BMC Cancer|July 7, 2024
KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancerSihui Zhu, Yuncheng Jin, Mingzhen Zhou, et al.
BMC Cancer|October 14, 2024
Nomograms predicting benefit after immunotherapy in oral bifidobacteria supplementation ICC patients: a retrospective studySihui Zhu, Yuncheng Jin, Juan Zhang, et al.
Optics Express|July 19, 2020
Wavefront reconstruction based on deep transfer learning for microscopyYuncheng Jin, Jiajia Chen, Chenxue Wu, et al.
Journal of Hepatocellular Carcinoma|February 13, 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving RadiotherapyZhan Shi, Sihui Zhu, Yuncheng Jin, et al.
Optics Express|November 25, 2018
Machine learning guided rapid focusing with sensor-less aberration correctionsYuncheng Jin, Yiye Zhang, Lejia Hu, et al.
Pageof 1